KnowTheStock
Log inCreate free account

Elevance Health, Inc.

ELV
S&P 500Hospital & Medical Service Plans · NYSE
$392.73last close · market cap 85.46 Billion
Compare with…
44.6SCORE / 100
Our verdictSELLModerate Growth but Declining, Stock Price Very HighQtr Ending 2026-09-30 · trend negative

Why Sell

Cash flow is strong; balance sheet is moderate; income statement is weak.

Next earnings: 2026-10-21 (BMO), EPS Forecast: $4.66

What is strong
  • Current Debt to Net Income Ratio is 0.27
  • Total Debt to Total Assets Ratio is 0.24
  • Cash from Operations Growth is 54.64%
  • Capital Expenditure is Low
  • Net Increase in Cash is Positive
What to watch
  • Revenue Growth is 3.6%
  • Operating Income Growth is -28.24%
  • Net Income Growth is -7.12%
  • Earnings Per Share (EPS) Growth is -4.13%
  • Net Margin is 2.55%
  • Current Asset to Current Liability Ratio is 1.47
  • Debt Ratio is 0.65
  • Investment Risk is High

What changed

Score by quarter

Downgraded from Hold to Sell in the Sep 2023 quarter: 60.0 → 54.4 (-5.6). This quarter: -1.1.

40506070Mar 2023Sep 2026

What the score is made of

Income statement31.0 -2.1
Balance sheet58.2 -0.0
Cash flow66.7 +0.0

Change vs previous quarter.

Key numbers · latest quarter

Revenue (TTM)201.83 Billion3.60 % growth
EPS23.43-4.13 % growth
Profit margin2.55 %Profit per $1 of sales
P-E ratio—Not available
Market cap85.46 BillionShares × price
Debt-equity ratio0.70Leverage
Dividend6.87Per share, annual
Next earnings2026-10-21BMO · EPS forecast $4.66
Better viewed in landscape mode.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.

About Elevance Health, Inc.

Elevance Health, Inc. is an American health insurance provider. Prior to June 2022, Elevance Health was named Anthem, Inc.

CEO
Gail Boudreaux
Employees
102,300
Sector
Health Care and Social Assistance
Exchange
NYSE
elevancehealth.com

Similar stocks

Loading…